Showing results (1-10 of 580) with videos related to

Sort By:
Pageof 58
Pharmacoeconomics|July 12, 2021
Valuing SF-6Dv2 in Australia Using an International ProtocolBrendan Mulhern, Richard Norman, John Brazier
Pharmacoeconomics|November 23, 2016
Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?Brendan Mulhern, Richard Norman, Paula Lorgelly, et al.
Health and Quality of Life Outcomes|November 28, 2015
Comparing the measurement equivalence of EQ-5D-5L across different modes of administrationBrendan Mulhern, Hannah O'Gorman, Neil Rotherham, et al.
Pharmacoeconomics|April 2, 2016
The Impact of Different DCE-Based Approaches When Anchoring Utility ScoresRichard Norman, Brendan Mulhern, Rosalie Viney
Pharmacoeconomics|September 9, 2018
One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State ValuationBrendan Mulhern, Richard Norman, Deborah J Street, et al.
The Patient|March 2, 2019
Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct ValidityMatthew Franklin, Clara Mukuria, Brendan Mulhern, et al.
Health and Quality of Life Outcomes|July 14, 2025
An Australian Value Set for the EQ-5D-Y-3LTianxin Pan, Bram Roudijk, Nancy Devlin, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 24, 2014
Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6DBrendan Mulhern, Clara Mukuria, Michael Barkham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Binary choice health state valuation and mode of administration: head-to-head comparison of online and CAPIBrendan Mulhern, Louise Longworth, John Brazier, et al.
Social Science & Medicine (1982)|October 16, 2025
Preference inversion in discrete choice experiments: A novel test of the emoji scaleThao Thai, Lidia Engel, Jemimah Ride, et al.
Pageof 58